Charles Explorer logo
🇬🇧

Interleukin-2 in the treatment of renal carcinoma

Publication at Faculty of Medicine in Hradec Králové |
2008

Abstract

Clear renal cell carcinoma is resistant to chemotherapy. Recombinant INF-alfa a rIL-2 supress proliferative activity of tumor cells and stimulate immune answer against tumor.

There is discussion about using of IL-2 in the treatment of RCC in this article.